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Abstract   
 
 
Background:  Coronary angiography is associated with a 4-15% chance of contrast-
induced nephropathy (CIN).  While the cause of CIN is still not understood, renal 
ischemia and free radical effects on tubular epithelial cells are thought to be responsible.  
In addition to increased hydration, the antioxidant properties of sodium bicarbonate are 
thought to decrease the direct toxic effects seen in CIN.  The question of this treatment’s 
efficacy has been asked since its inception, and no definitive conclusion has been 
reached.  The purpose of this systematic review is to compare and contrast the most 
current randomized trials, assessing the quality of the studies involved, and to give a 
practicing clinician a more complete understanding of the outcomes. 
Methods:  Exhaustive search of available medical literature from 2006 to the present for 
randomized control trials regarding contrast-induced nephropathy in patients undergoing 
non-emergent coronary angiography.  The reviewed studies examined the significance of 
sodium bicarbonate in addition to hydration versus hydration alone, measured by pre- and 
post-operative renal function. 
Results:  The five studies reviewed do not agree on the efficacy of sodium bicarbonate 
administration for renal prophylaxis, although all state that increased hydration is the 
gold standard, and that sodium bicarbonate is not associated with increased adverse 
effects.  Multiple studies showed no statistical significance of renal protection when 
compared to hydration alone, although methods of administration and several other 
confounders were identified when the trials were analyzed en masse.   
Conclusion:  Repeated, definitive, single protocol studies have yet to determine the 
efficacy of sodium bicarbonate administration in patients undergoing cardiac 
angiography, but all current studies can agree that use of this compound for renal 
prophylaxis is not associated with an increased risk to the patient. 
Keywords:  Coronary angiography, nephropathy, catheterization, sodium bicarbonate 
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Contrast-Induced Nephropathy and Prophylactic  
Administration of Sodium Bicarbonate with Coronary Angiography 
 
BACKGROUND 
 Patients undergoing elective coronary angiography are at risk of several 
complications, one of the most common of which is contrast-induced nephropathy 
(CIN),1 However, administration of contrast media is imperative for imaging during 
coronary angiographies and percutaneous interventions.  Incidence of CIN occurrence 
can vary between 2% in low-risk populations to more than 50% in high risk patients,2 
with up to 15% in patients identified with mild renal impairment.1  CIN is associated with 
several adverse outcomes, the most noteworthy of which are an increased need for 
hemodialysis, persistent decline in renal function, and increased mortality.1,2  Contrast-
induced nephropathy is also strongly associated with an extended inpatient care period, 
and increased costs of care.3,4  In hospitalized patients, CIN has become the third-leading 
cause of acute renal failure (ARF) affecting 12% of individuals. This is second only to 
hypotension and post-surgical complications.4,5  In those patients needing hospital care 
after acquiring CIN, the mortality rate is 34%.6  Several factors increase a patient’s risk 
of CIN, including but not limited to chronic kidney disease (CKD), volume and type of 
contrast media used, and pre-existing patient conditions.5  Diabetes, male gender, 
congestive heart failure (CHF), increased age, anemia, and a decreased circulating blood 
volume are just some of the conditions that increase a patient’s risk of CIN.3,4,7,8   
 The mechanism of renal damage from contrast-induced nephropathy is not well 
understood.  The most commonly accepted theories focus on renal ischemia and tubular 
 8 
epithelial cell toxicity.9,10  Renal ischemia is thought to be a consequence of the 
vasoconstrictive effects of the hyperosmolar renal blood flow during contrast 
administration, while the free radical nature of the contrast media in the renal tubule is 
thought to be responsible for the tubular epithelial cell toxicity.10 
 Several strategies have been proposed to provide renal protection during 
angiographic procedures.  Plasma-expanding fluids (ie, mannitol), diuretics, dopamine 
and hemofiltration have all been evaluated with limited results.11-20  The use of N-
acetylcysteine (NAC) has shown some promise, but considerable heterogeneity in study 
parameters and outcomes reflect conflicting conclusions on NAC’s effectiveness.10  
Volume expansion in the peri-procedural period remains the only undisputed modality to 
have shown any statistical promise concerning CIN.21   
 Sodium bicarbonate is often used as a means of preventing CIN, based on sodium 
bicarbonate’s antioxidant properties and alkalinizing abilities in the renal tubule.12  
Bicarbonate reacts and neutralizes peroxynitrite, a species of reactive oxygen created by 
nitric oxide in the renal tubule,22 and it is also thought to inhibit the Harber-Weiss 
reaction.  This reaction creates a superoxide from a hydrogen peroxide ion and free 
oxygen, and is activated in acidic environments.23  By increasing the pH of the renal 
tubule, this reaction is disrupted, therefore decreasing cytotoxic damage to the epithelial 
cells in the kidney. 
 This systematic review was performed to evaluate the potential and practical 
effects of sodium bicarbonate administration compared to normal hydration, as it pertains 
to preventing contrast-induced nephropathy.  To accomplish this, the most pertinent and 
current randomized research trials have been gathered to compare, contrast, and evaluate 
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the protocols, outcomes, interpretations, and validity of those studies in a comprehensive 
manner.  Due to its ease of administration in angiographic procedures, its low cost, and 
its apparent lack of adverse effects, sodium bicarbonate could potentially be a standard of 
treatment in all patients undergoing coronary imaging with renal insufficiency. 
 
METHODS 
Search Protocol 
 This systematic review analyzed the most current research that enriches our 
understanding of CIN and the use of sodium bicarbonate to prevent it.  Therefore, only 
studies published in the last 4 years contrasting sodium bicarbonate treatment with 
normal hydration were included.  Only studies of prospective, randomized trials were 
included in this review, although cohort and case controlled studies were referenced for 
background and ancillary information.   
 An exhaustive literature search was conducted using the comprehensive search 
engines Medline, CINAHL, and ISI Web of Science.  The following terms were used: 
coronary angiography, nephropathy, sodium bicarbonate, and contrast-induced 
nephropathy.  Results of this search were compared, collated, and cross-referenced, 
checking for duplications of studies and critical outcomes.  The reference sections of 
relevant articles were reviewed for pertinent information associated with the subject 
matter.  All articles in the systematic review were then critically appraised and ranked 
using a standard Jadad score for validity (Table 1). 
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Inclusions/Exclusions 
 Inclusion criteria limited the search to English language publications of non-
emergent coronary procedures on adult human subjects using sodium bicarbonate as the 
primary intervention.  Exclusion criteria were any randomized controlled trials published 
before 2006, and those studies comparing interventions other than sodium bicarbonate 
with normal hydration.   
RESULTS 
 Results of the online search illuminated seventy-five possible journal articles for 
evaluation using the search terms included, on the three databases.  After eliminating 
duplications and irrelevant sources (letters, opinion articles, etc), the inclusion/exclusion 
criteria were applied to fourteen sources.  A final number of five prospective, 
randomized, controlled trials were evaluated for this systematic review.  A summary of 
their pertinent information can be found in Table 2. 
 
Vasheghani-Farahani et al 
 Taking place in Tehran, Iran at the Tehran Heart Center, Vasheghani-Farahani et 
al24 conducted a single center study which was composed of 265 patients, randomized 
into two experimental arms in a double-blind fashion, who were undergoing elective 
coronary angiography.  All participants had a stable serum creatinine of 1.5mg/dl or 
greater within two weeks of the procedure, which is indicative of decreased renal 
function.  Parameters between the two groups were similar, with a mean age of 63.3 
years, and a population consisting of 83% males.  Patients were enrolled in either the 
saline arm, receiving 1075ml of 0.9% normal saline, or the bicarbonate arm which 
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received 75ml of 8.4% bicarbonate mixed with 1000ml of normal saline.  Administration 
was equal in both arms, with an initial bolus of 3ml/kg for 1 hour, then decreasing to 
1ml/kg/hr for 6 hours after the procedure.  Fluid volume was limited at 110kg, and all 
diuretics were withheld on the day of the procedure.  Three formulations of contrast agent 
were used, Iohexol, a non-ionic, low-osmolar agent was used in 254 patients.  Iohexol 
plus amidotrizoic acid, a non-ionic, high-osmolar agent was used in 8 patients, and 
Iodixanol a non-ionic, iso-osmolar agent was utilized in 2 patients.  The volumes of 
contrast media used in the two groups were 113.2ml and 115.0ml.  Serum creatinine was 
assessed prior to the procedure, as well as at days 2 and 5 after the procedure.  Urine pH 
was measured prior to angiography, and at the first spontaneous voiding after.  Primary 
endpoint of the study was the development of CIN, measured as an absolute or relative 
increase in the serum creatinine by 0.5mg/dl or 25%, respectively.  Secondary outcomes 
were at least a 25% decrease in the baseline GFR within 48 hours, duration of hospital 
stay, and urine pH after the initial bolus of contrast.24 
 Of the 265 participants, 40 were excluded from the final analysis due to variance 
from the study protocol, with 3 patients receiving increased hydration, 1 patient was 
enrolled with a GFR<20ml/min, and 36 patients with that were determined to have 
unstable creatinine levels based on the measurements just prior to the procedure.  These 
36 participants were included in the preliminary analysis based on the intent-to-treat 
principle.  The final analysis revealed no statistically significant differences between the 
two groups, even when the 36 patients were included.  Within the saline arm, 7 of the 
patients (5.9%) satisfied the primary endpoint, while 9 patients (7.4%) in the bicarbonate 
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arm were diagnosed with primary endpoint CIN (p=0.6).  Serum creatinine levels at day 
5, and secondary endpoints did not significantly differ (p=0.6, p=0.3). 24  
 
Adolph et al 
 Adolph et al,25 a single-center, prospective, randomized, controlled trial in 
Rostock, Germany involved 148 subjects undergoing elective angiography or PCI with 
stable renal insufficiency.  Renal insufficiency was defined as two serum creatinine 
measurements greater than 1.2mg/dl (but with no more than a 5% difference the two), 
within a 12 week period prior to the procedure.  Subjects were randomized in a double-
blinded fashion into two groups.  The saline group consisted of 72 patients who received 
154mEq of sodium chloride in 846ml of D5W, while the bicarbonate group was made up 
of 76 patients who received 154mEq of sodium bicarbonate in 846ml of D5W.  
Participants did not statistically differ in demographic, clinical, or biochemical 
characteristics, with a mean age of 70.1 in the bicarbonate group, and 72.7 in the saline 
group (p=0.543).  Of the total participants, 77.9% were male (n=113).  Fluids were 
administered at rates of 2ml/kg/hr for 2 hours prior to the procedure, and this was 
decreased to 1ml/kg/hr during and for 6 hours after the procedure.  Diuretics were 
withheld the day of the procedure.  Non-ionic, iso-osmolar Iodixanol was used in all 
patients, with mean volumes of 141ml in the bicarbonate group, and 138ml in the saline 
group (p=0.532).  Serum creatinine, cystatin C, plasma viscosity, and urinary enzymes 
were recorded prior to the procedure to establish a baseline, and again at days 1 and 2.  
The primary endpoint was defined as an increase in serum creatinine of > 0.5mg/dl or 
25% above baseline within days the first 48 hours after the procedure.  Significant 
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changes in cystatin C, plasma viscosity, or urinary enzymes were considered secondary 
endpoints.25 
 In this particular study, only 145 patients had a complete follow-up.  Two patients 
were lost due to emergencies arising from coronary artery bypass grafting and pulmonary 
edema.  Another patient refused follow-up after not completing the study.  Final analysis 
revealed no statistical significance in the primary endpoint.  The sodium bicarbonate 
group had 3 patients (4.2%), and the saline group had 2 patients (2.7%) that were 
diagnosed with CIN (p=0.614).  There were no significant differences in the secondary 
endpoints.  Hospital stays were increased in patients diagnosed with CIN, but all 5 
patients returned to baseline serum creatinine levels within 14 days of the procedure.25 
 
Mauro et al 
 Mauro et al21 performed a prospective, randomized trial, consisting of 502 
patients (mean age 74, 41% female) undergoing planned coronary angiography with or 
without PCI, was performed in a single-blinded fashion at a single center in Prato, Italy.  
All patients included in the trial had estimated creatinine clearances of <60ml/min.  Of 
the 502 subjects, 252 were assigned to a standard hydration therapy of 0.9% normal 
saline, given at 1ml/kg/hr for 12 hours before and after the procedure.  The remaining 
participants were assigned to the sodium bicarbonate group, and received a mixture of 
sodium bicarbonate and 5% dextrose with water at 154mEq/l, respectively.  This solution 
was administered at 3ml/kg for 1hour before the procedure, and at 1ml/kg/hr for 6 hours 
after.  All patients received oral NAC twice daily from the day prior to the procedure 
until the day after the procedure.  Fluid restrictions were placed on patients classified 
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with left ventricular heart failure.  Iodixanol contrast media, a nonionic, iso-osmolar 
agent, was used in all cases, with an average contrast volume used of 170ml in the saline 
group, and 160ml used in the bicarbonate group.  Serum creatinine levels were measured 
at admission, and routinely on days 1-5 and on day 10 in the post-procedural timeline.  
An additional assessment was taken at 1 month on individuals who were diagnosed with 
CIN to establish persistent renal impairment.  The primary endpoint of the study was an 
increase of 0.5mg/dl, which the study defined as CIN, within five days after the 
procedure.  Secondary endpoints included an increase >25% in the baseline serum 
creatinine, in-hospital death, acute pulmonary edema, and a need for either dialysis or 
hemofiltration.21 
 In total, 54(10.8%) patients in the study developed CIN, as defined by the primary 
endpoint, 29 (11.5%) in the saline group, and 25 (10.0%) in the bicarbonate group 
(p=0.60).  No statistical difference was noted in secondary endpoints, with even 
distribution of adverse events across both arms of the study (p=0.13).21 
 
Brar et al 
 The study authorized by Brar et al,9 looked at patients undergoing elective 
coronary angiography with or without PCI, at a single center in Los Angeles, all with 
moderate to severe CKD as defined by a glomerular filtration rate of 60mL/min or less, 
and at least one of the following: age over 75 years, diabetes mellitus, hypertension, or 
congestive heart failure.  Patients in this prospective trial were randomly sorted into a 
single-blind study consisting of 353 subjects.  Populations were similar in respect to co-
morbidities, with a mean age of 71, and a total of 36.2% female participants.  Participants 
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were randomly sorted into two arms, a saline group consisting of 178 participants 
receiving 0.9% normal saline, and a bicarbonate group with 175 participants receiving 
150mEq of sodium bicarbonate in 1L of 5% dextrose with water.  Infusion rates were 
equal in the two groups, at 3ml/kg for 1 hour prior to the procedure, and decreased to 
1.5ml/kg during the procedure and for 4 hours following it.  Hydration levels were 
limited to those needed in a 100kg individual.  Ioxilan, a non-ionic, low-osmolar contrast 
media was used in all participants, with an average administration of 137ml in the saline 
group, and 126ml in the bicarbonate group.  Procedural duration was also noted in this 
study, but differences were not statistically significant between the two groups(p=0.08).  
Serum creatinine levels were measured as patients were admitted to the treatment center, 
and subjects were asked to have them drawn again on days 1 and 2 following the 
angiography.  All serum creatinine levels were followed until they either returned to 
baseline, or established a new baseline with impaired kidney function.  The primary 
endpoint of the study was the development of CIN, defined in this study as a 25% 
decrease in the GFR from the baseline using the lowest recorded rate measured post-
procedurally.  Secondary endpoints included an increase of >25% in the serum creatinine, 
dialysis within 30 days after the procedure, or any/all cause mortality.  Those participants 
who developed CIN were asked to return for another GFR within a 2 to 8 week period to 
establish whether renal impairment persisted.9 
 In total, 323 of the original 353 were included in the primary CIN analysis.  
Thirty patients were lost to follow-up because they either did not undergo the 
angiography (n=3), or they did not have proper GFR data 1-4 days after the procedure 
(n=27).  At the end of the primary analysis, 45 (13.9%) patients in the study developed 
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CIN, as defined by the primary endpoint.  The saline group had 24 (14.6%) patients who 
met the primary endpoint, while the bicarbonate group had 21 (13.3%) patients (p=0.82).  
Secondary endpoints were not statistically significant between the two groups, with the 
recording of adverse events extended to 6 months.  These measurements included the 
thirty individuals from the study that were lost to follow up, based on the intent-to-treat 
principle.9 
 
Tamura et al 
 Tamura et al,26 a prospective, controlled, single-blinded trial, took place at two 
hospitals in Oita, Japan.  In total, 144 patients undergoing elective angiography or PCI, 
with a measured serum creatinine of 1.1mg/dl or greater, were randomized to receive 
either standard hydration with normal saline, or standard hydration with a single bolus of 
sodium bicarbonate (20ml) five minutes prior to contrast exposure.  A total of 72 
individuals were assigned to each group.  Characteristics relating to clinical, procedural, 
and biochemical parameters were not statistically different.  Men made up 87.5% of the 
population (n=126), with a mean age of 72.8 years for all subjects.  Participants in both 
groups were administered 0.9% normal saline at 1ml/kg/hr for 12 hours before and after 
the procedure.  Fluids were limited to 80ml/hr in all patients, and were decreased by half 
in individuals suffering from CHF with an ejection fraction <40%.  Diuretics were 
withheld the day of the procedure.  Non-ionic, low-osmolar Iohexol was used in all 
patients.  Contrast volume was an average of 82.1ml in the bicarbonate group, and 87.8ml 
in the normal hydration group.  Serum creatinine levels were measured prior to the 
procedure, and daily for 3 days afterward.  Additional creatinine measurements were 
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taken in all individuals who had a decrease in renal function after the procedure.  All 
creatinine levels were taken using an enzyme method that differs from the technique used 
in many Western countries, resulting in a decreased measurement by an average of 
0.2mg/dl.  Arterial gas and urine pH measurements were also taken before and after the 
procedure.  The definition of the primary endpoint was an increase from the baseline 
serum creatinine of > 25% or 0.5mg/dl, defined as CIN, within 3 days after the 
procedure.  Secondary endpoints were percentage changes of serum creatinine from the 
baseline, and adverse clinical events within one week of the procedure, including 
pulmonary edema, renal failure requiring dialysis or hemofiltration, or death.26 
 All subjects finished the trial with complete follow-up.  All 144 participants were 
included in the final analysis.  There was statistical difference in the two experimental 
arms, with 1 patient (1.4%) in the bicarbonate arm, and 9 patients (12.5%) in the normal 
hydration arm meeting the primary endpoint criteria for CIN (p=0.017).  Satisfaction of 
secondary endpoints showed percentage changes of creatinine that were significantly 
different (p<0.001), with insufficient statistical variance of adverse events, with only 1 
patient in the normal hydration arm needing dialysis (p=0.99).  Measurements of urinary 
pH and arterial blood gases showed significant differences when compared to the normal 
hydration group (p<0.001).26 
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DISCUSSION 
Validity 
 In this analysis, all studies chosen for systematic review were randomized, 
controlled trials of high quality with good samples sizes.  They relied on similar 
exclusion criteria with similar populations from around the globe, including Iran, 
Germany, Japan, Italy, and the US.  Jadad Validity scoring was used to evaluate the 
potential strength of each trial’s outcomes (Table 1).  Each article was given a validity 
score, with possible rankings from 0-5.  Two trials, Vasheghani-Farahani et al24 and 
Adolph et al,25 both scored the highest possible with 5 points apiece, while all other 
studies scored a 3 on the Jadad scale.  In those studies9,21,26 that scored a 3, all failed to 
score a 5 because they stated they were single-blinded, or did not mention if they were 
single or double blinded. 
 
Outcomes 
 In reviewing the results, the majority of evidence suggests that there is limited, if 
any, benefit from the use of sodium bicarbonate over normal hydration alone concerning 
contrast-induced nephropathy.  All of the studies agreed that the standard therapy of 
hydration decreased the occurrence of CIN, but only Tamura et al26 showed statistical 
reductions in the incidence of CIN when patients were administered sodium bicarbonate 
over normal hydration alone.  These results are somewhat confusing, especially 
considering the administration of sodium bicarbonate for coronary angiography 
procedures, and angiographic imaging in general, is a very commonplace procedure. 
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 Considering the mechanisms by which CIN is thought to occur, either by renal 
ischemia or free radical toxicity, the evidence shows that ischemia may play the larger 
role.  Urinary pH was measured in only 2 studies,24,26 but both studies saw a marked rise 
in the urinary pH that was expected in the sodium bicarbonate groups.  The increased pH 
demonstrates that while sodium bicarbonate was available for free radical scavenging in 
the kidney, the total effect may not be as large as thought before.  This is consistent with 
the utilization of increased hydration for prevention of CIN, as the increased fluid 
accessible to the glomerular complex may offset the ischemia that would otherwise 
damage the nephron. 
 There was no significant divergence between the two therapies concerning 
adverse events in any of the studies.  Complications of pulmonary edema, dialysis, 
hemofiltration, and all cause mortality were not statistically noteworthy when the two 
treatments of sodium bicarbonate and normal hydration were contrasted. 
 
Limitations of Study 
 Endpoint variance— Of the presented studies, one major difference seen 
between them was defining CIN, both in serial testing and duration.  For instance, Mauro 
et al21 defined CIN as an increase of >0.5mg/dl in the serum creatinine within two days.  
Two studies24,25 defined CIN as either an increase in the serum creatinine of >0.5mg/dl or 
a relative increase of 25%, within 2 days.  Another study26 defined CIN in the same way, 
but within 3 days.  Brar et al,9 did not define CIN using serum creatinine at all, but 
instead used estimated GFR levels.  The authors of this trial acknowledged that 
evaluating acute renal changes with GFR is not as well established as the use of serum 
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creatinine.  The literature notes that the development of CIN peaks at post-procedural 
days 3-5, however while some of the present studies monitored renal function during 
these days, they were not the primary outcome.  Possible reasons for the lack of follow-
up on days 3-5 may be problems with subject compliance and reliability outside the 
hospital setting, although this is not expressly stated.  Resumption of diuretics, asthmas 
medications, and other environmental factors were also not monitored once the patient 
was discharged from the hospital in any of the studies. 
 Another note should also be made that Tamura et al26 used a different method to 
measure the serum creatinine than the common Jaffe method used in Western countries, 
resulting in a serum creatinine that is 0.2mg/dl lower on average.  This method was used 
in all participants, and its effect on the study is unknown. 
 Protocol- In the current review, one major confounder were the protocols utilized 
to administer both the interventions and comparison controls in the studies.  For instance, 
infusion rates varied from study to study, with pre-procedural rates ranging from 
1ml/kg/hr x 12 hours to 3ml/kg/hr x 1 hour.  In one study, Mauro et al,21 the infusion 
rates varied between the two experimental arms, with the bicarbonate group receiving 
much less hydration both pre-procedurally and post procedurally.  The amount of sodium 
bicarbonate utilized in each study was different, as was the volume of contrast media 
injected into the patient, although it is unknown if these differences are of statistical 
significance when compared across the different trials.   
 Another disparity revealed in this review was the solution employed to deliver the 
sodium bicarbonate.  While an optimal study would have compared normal saline vs. 
normal saline with sodium bicarbonate as an intervention, as in 3 of the trials; both Brar 
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et al9 and Mauro et al21 compared normal saline to sodium bicarbonate mixed with D5W.  
The use of this crystalloid solution allows for differences in hydration, as some volume of 
the free water is lost into the interstitial space after the glucose has been metabolized, 
whereas a greater amount of the saline solution remains in the intravascular space to be 
available for the glomerular complex to filter.   
 Lastly, the given studies used different types of contrast media for visualization 
during angiography.  All were non-ionic, but variations in the osmolarity of the different 
media result in fluctuations in the CIN effect size.  Iso-osmolar contrast has been proven 
to have a lower incidence of CIN, when compared to low-osmolar contrast (6.1%-15.4% 
incidence).27  Two studies,21,25 used iso-osmolar agents, two studied9,26 used low-osmolar 
agents, and Vasheghani-Farahani et al24 used all three levels of osmolarity, ranging from 
low to iso to high, although 96% of their patients were administered the low-osmolar 
agent Iohexol.  While this may not change the results of an individual study, when 
applied to a systematic review of several studies, the implications show that differing 
protocols across all studies make a larger perspective analysis difficult. 
 
CONCLUSIONS 
 While there exists strong research showing that sodium bicarbonate is not 
effective in the treatment of contrast-induced nephropathy; variations in dosage, 
administration, hydration protocol, and outcomes confound the evidence.  Throughout all 
studies, no statistically significant evidence showed sodium bicarbonate to be deleterious 
to the patient’s health, or increase the risk of adverse events.  The wise clinician will use 
this evidence to augment treatment at their own discretion, evaluating a patient’s renal 
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status, pre-existing risk factors, and potentially harmful outcomes if sodium bicarbonate 
is employed or not.   
 Future avenues of study should focus on resolving a universal definition and 
method of measurement for contrast induced nephropathy.  It is important that these 
studies use equivalent protocols for both experimental groups, leaving only the 
administration of sodium bicarbonate as a variable.  While all of the studies were single-
center in nature, a broad multicenter study using the above recommendations could help 
future clinicians decide to use sodium bicarbonate in their practice, or conclude that this 
treatment is an antiquated prophylactic treatment without statistically reliable results.  
Either way, this treatment is a low-cost, non-harmful, and easily administered therapy 
that almost any patient can be treated with. 
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TABLES 
 
TABLE 1: Jadad Validity Scoring 
 
VALIDITY PROTOCOL SCORE 
Was the trial/study randomized? 1 
Was the method of randomization appropriate for the study, and was it described? 1 
Was the study double-blinded? 1 
Was the method of blinding the study appropriate and described? 1 
Were dropouts/withdrawals for the study accounted for? 1 
Deduction for inappropriate randomization. Subtract (-1) 
Deduction for inappropriate double blinding. Subtract (-1) 
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TABLE 2: Summary Matrix of Literature 
 
Author Study 
Size & 
Type 
Population  Intervention 
& 
Comparison 
Outcomes Jadad 
Score 
Vasheghani-
Farahani  
et al24 
(10/2009) 
 
N=265 
RCT 
Patients with stable renal 
disease, defined as a 
serum creatinine 
>1.5mg/dl 
Sodium Bicarbonate 
with Normal Saline 
vs. Normal saline 
 
 
Serum creatinine increase 
of  >0.5mg/dl or  >25% 
from baseline within 2 
days 
5 
Adolph et al25 
(9/2008) 
N=145 
RCT 
Patients with stable renal 
disease defined as 2 
serum creatinine levels 
>1.2mg/dl 
Sodium Bicarbonate 
with D5W vs. 
Sodium Chloride 
with D5W 
 
 
Serum creatinine increase 
of  >0.5mg/dl or >25% 
from baseline within 2 
days 
5 
Mauro et al21 
(8/2009) 
N=502 
RCT 
Patients with stable renal 
disease defined as a GFR 
<60ml/min 
Sodium Bicarbonate 
with D5W vs. 
Normal Saline 
 
 
Serum Creatinine increase 
of  >0.5mg/dl within 2 
days 
3 
Brar et al9 
(9/2009) 
N=353 
RCT 
Patients with stable renal 
disease defined as a GFR 
<60ml/min and 1 defined 
comorbidity. 
 
Sodium Bicarbonate 
with D5W vs. 
Normal Saline 
 
 
GFR decrease of >25% 
within 4 days 
3 
Tamura et al26 
(10/2009) 
N=144 
RCT 
Coronary angiography in 
patients with baseline 
creatinine of 1.1mg/dl  
Sodium Bicarbonate 
bolus with Normal 
Saline vs. Normal 
Saline 
Serum creatinine increase 
of  >0.5mg/dl or 25% 
from baseline within 3 
days 
3 
  
